◆ 会议时间:2020年2月24-27日
◆ 会议地点:美国 圣迭戈(圣地亚哥)/San Diego
◆ 会议简介:
2020年第25届国际AKI&CRRT大会/国际危重肾脏病护理进展大会(AKI&CRRT 2019)将于2020年2月24-27日在美国圣地亚哥举行,会议由UAB-UCSD提供支持。
CRRT会议将继续对快速发展的危重肾脏病和CRRT(连续肾脏替代疗法)领域进行全面的阐述。会议将强调我们对危重疾病病理生理学、急性肾损伤、脓毒症管理新策略、多器官衰竭、生物标志物的开发和使用、CRRT技术的进展以及适当应用这些技术方面等方面认识的最新进展。今年大会将再次提供一个会前AKI研讨会,将全面回顾这一领域的最新进展(未经许可,禁止复制摘录转载本站任何内容-领域国际医学会议网)。
Conference Topics:
Epidemiology and Outcomes from AKI
Research in AKI
RRT Technique Characteristics
RRT Applications and Targeted Interventions
New Technology
RRT Research
Nursing Issues
Dear Colleague,
We would like to invite you to join us for the upcoming25th International Conference on Advances in Critical Care Nephrology – AKI & CRRT 2020.
Our 25th Anniversary CRRT Conference will continue to provide a comprehensive coverage of the rapidly developing field of Critical Care Nephrology and CRRT. It highlights the recent advances in our understanding of pathophysiology of critical illness, acute kidney injury, emerging strategies in the management of sepsis, multiorgan failure, development and use of biomarkers, technical advances in CRRT and the appropriate utilization of these techniques. This year’s program presents exciting new developments and evidence for assessing critically ill patients, the role of the microbiome and advances in the global burden of AKI CRRT. A mix of invited lectures, controversies, interactive workshops, tutorials, poster sessions and panel discussions are planned to continue the tradition of multidisciplinary interactions.
Again this year we are offering a Pre-Conference AKI Symposium titledChanging Paradigms in Acute Kidney Injury: From Mechanisms to Management.The workshop will provide a comprehensive review of the most recent developments in the field and include the proceedings from the recent ADQI conferences on AKI in the era of Big Data and Renal Recovery. We hope that this course will provide participants an opportunity to interact with experts in the field and emerge with a better understanding of this rapidly evolving area.
2020 Conference Topic Highlights:
•Meet The Expert Sessions
Interact and Learn from Experts on How to Evaluate and Manage ICU Patients with Difficult Clinical Problems
•Organ Dysfunction in the Critically Ill Patient
Emerging Concepts in Organ Cross-talk, Sepsis, Microcirculation and Oxidative Stress, Infections
•Raising Awareness of Acute Kidney Injury (AKI)
The ISN AKI 0by25 initiative Global snapshot of AKI, the Global Burden of Disease, Strategies
for Raising Awareness and Providing Tools for Education and Training, Creating Infrastructurefor Dialysis in Resource Poor Countries
•Controversies in Management of the Critically Ill Patient
Diuretic Use for AKI, Antibiotic Nephrotoxicity, RRT for End Stage Liver Disease,Protecting the Kidney; Results from Trials in AKI and Heart Failure
•Challenges and Controversies in Renal Support & CRRT
When to Start and Stop, Bicarbonate Use, Co2 Removal, RRT for Sepsis, Pharmacokineticsof Antibiotics, Energy Expenditure in RRT
•Biomarkers for Management of Critically Ill Patients
Risk Stratification, Surveillance, Diagnosis, Targeted Intervention and Prognosis
•Special Sessions for Nurses and Allied Personnel
Skills Assessment, Workshops on CRRT, Plasma Exchange, Establishing QualityMetrics for RRT in AKI
•Special Pre-ConferenceWorkshop
ThePractice Based Learning in CRRTworkshop (now 2 days!) will utilize case based discussions and interactions with machines to train participants on setting up and delivering CRRT
As always, we are working to provide the right environment to foster learning and mutually beneficial communications and collaborations. We hope that you will join us to share your knowledge and experience as it is through multidisciplinary interactions that we will gain a better understanding of critical illness and it is only through our collective efforts that we will improve the lives of our patients. We look forward to welcoming you to San Diego for the 25th time. Please note that we have shifted our week days, the conference is now Monday through Thursday.
Ravindra L. Mehta, MBBS, MD, DM, FACP, FRCP(UK)
Chairman, Organizing Committee
重要日期:
Online Registration |
Opens in October |
Abstract Submission |
Opens August 1st |
Deadline for Abstracts |
December 12, 2019 |
Notification of Abstract Acceptance |
January 5, 2020 |
Postmark deadline for early bird registration |
January 7, 2020 |
Hotel Reservation Deadline |
January 28, 2020 |
On-site Registration Fees Begin |
February 5, 2020 |
Pre-Conference Elective CRRT Workshop |
Sunday/Monday, February 23 & 24, 2020 |
Pre-Conference Elective AKI Symposium |
Monday, February 24, 2020 |
Poster Mounting and Viewing |
Monday, February 24, 2020 |
Plenary and Workshop Sessions |
February 24-27, 2020 |
AKI & CRRT 2020 注册费:
Registration Fee does not include Elective AKI Symposium or CRRT Workshop.
1. Early Bird Registration : On or before January 7, 2020
2. Pre-registration : January 8, 2020 - February 4, 2020
3. Registration : February 5 - February 27, 2019 On-Site
The registration fee includes CME accreditation, conference syllabus on digital media, coffee in the morning and at breaks, receptions on Monday and Tuesday, and lunches on Wednesday and Thursday. On-site registration will begin on Sunday, February 23. Poster Viewing will begin on Monday evening February 24.
Registration Fees
(Subject to change. Include standard conference workshops)
|
Early Bird Registration
|
Pre-registration
|
Registration
|
Physicians / Other (MD, PhD, etc.)
With Multimedia Package
|
$730
$930
|
$830
$1030
|
$895
$1095
|
Physicians In Training*
With Multimedia Package
|
$530
$730
|
$630
$830
|
$660
$860
|
Nurses
With Multimedia Package
|
$530
$730
|
$630
$830
|
$660
$860
|
Allied Personnel(Dieticians, Pharmacists)
With Multimedia Package
|
$530
$730
|
$630
$830
|
$660
$860
|
Industry Professional
With Multimedia Package
|
$730
$930
|
$830
$1030
|
$895
$1095
|
Elective CRRT Workshop and
AKI Symposium Fees |
Early Bird Registration
|
Pre-registration
|
Registration
|
Two Day (CRRT) or Full Day (AKI)
AKI With Multimedia |
$250
$375
|
$270
$395
|
$290
$415
|
◆ 参会对象:
政府代表、医院管理者、科室主任、副主任、医生及从相关领域研究的专家、科研人员、医药企业等。
|